The Colitis Drug market is a subset of the Gastrointestinal Drugs market, which includes drugs used to treat a variety of gastrointestinal disorders. Colitis drugs are used to treat inflammatory bowel diseases such as ulcerative colitis and Crohn's disease. These drugs are typically administered orally or intravenously, and can include corticosteroids, immunomodulators, and biologics. Corticosteroids are used to reduce inflammation, while immunomodulators are used to suppress the immune system and reduce inflammation. Biologics are used to target specific proteins in the body that are involved in the inflammatory process. Some companies in the Colitis Drug market include AbbVie, Amgen, AstraZeneca, Janssen, Merck, Pfizer, and Takeda. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
